Importer of Controlled Substances; Notice of Registration, 17967 [2011-7537]

Download as PDF 17967 Federal Register / Vol. 76, No. 62 / Thursday, March 31, 2011 / Notices By order of the Commission: Issued: March 28, 2011. William R. Bishop, Hearings and Meetings Coordinator. Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration [FR Doc. 2011–7671 Filed 3–29–11; 11:15 am] BILLING CODE 7020–02–P JOINT BOARD FOR THE ENROLLMENT OF ACTUARIES Meeting of the Advisory Committee; Meeting Joint Board for the Enrollment of Actuaries. AGENCY: Notice of Federal Advisory Committee meeting. ACTION: The Executive Director of the Joint Board for the Enrollment of Actuaries gives notice of a closed meeting of the Advisory Committee on Actuarial Examinations. SUMMARY: The meeting will be held on April 29, 2011, from 8:30 a.m. to 5 p.m. DATES: The meeting will be held at Mercer, 4400 Comerica Bank Tower, 1717 Main Street, Dallas, TX 75201. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Patrick W. McDonough, Executive Director of the Joint Board for the Enrollment of Actuaries, 202–622–8225. Notice is hereby given that the Advisory Committee on Actuarial Examinations will meet at Mercer, 4400 Comerica Bank Tower, 1717 Main Street, Dallas, TX, on April 29, 2011, from 8:30 a.m. to 5 p.m. The purpose of the meeting is to discuss topics and questions that may be recommended for inclusion on future Joint Board examinations in actuarial mathematics, pension law and methodology referred to in 29 U.S.C. 1242(a)(1)(B). A determination has been made as required by section 10(d) of the Federal Advisory Committee Act, 5 U.S.C. App., that the subject of the meeting falls within the exception to the open meeting requirement set forth in Title 5 U.S.C. 552b(c)(9)(B), and that the public interest requires that such meeting be closed to public participation. wwoods2 on DSK1DXX6B1PROD with NOTICES SUPPLEMENTARY INFORMATION: Dated: March 25, 2011. Patrick W. McDonough, Executive Director, Joint Board for the Enrollment of Actuaries. [FR Doc. 2011–7518 Filed 3–30–11; 8:45 am] BILLING CODE 4830–01–P VerDate Mar<15>2010 11:23 Mar 31, 2011 Jkt 223001 the following basic classes of controlled substances: DEPARTMENT OF JUSTICE By Notice dated October 8, 2010, and published in the Federal Register on October 20, 2010 75 FR 64744, Hospira Inc., 1776 North Centennial Drive, McPherson, Kansas 67460–1247, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Remifentanil (9739), a basic class of controlled substance listed in schedule II. The company plans to import Remifentanil for use in dosage form manufacturing. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and determined that the registration of Hospira Inc. to import the basic class of controlled substance is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Hospira Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed. Dated: March 21, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. Drug Raw Opium (9600) ....................... Concentrate of Poppy Straw (9670). Schedule II II The company plans to import narcotic raw materials for manufacturing and further distribution to its customers. The company is registered with DEA as a manufacturer of several controlled substances that are manufactured from raw opium, poppy straw, and concentrate of poppy straw. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Cody Laboratories, Inc. to import the basic classes of controlled substances is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. DEA has investigated Cody Laboratories, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Dated: March 21, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2011–7542 Filed 3–30–11; 8:45 am] BILLING CODE 4410–09–P [FR Doc. 2011–7537 Filed 3–30–11; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration By Notice dated October 19, 2010, and published in the Federal Register on October 26, 2010, 75 FR 65658, Cody Laboratories Inc., 601 Yellowstone Avenue, Cody, Wyoming 82414–3921, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of PO 00000 Frm 00151 Fmt 4703 Sfmt 4703 Importer of Controlled Substances; Notice of Registration By Notice dated November 19, 2010, and published in the Federal Register on December 3, 2010 75 FR 75494, Mylan Technologies, Inc., 110 Lake Street, Saint Albans, Vermont 05478, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the following basic classes of controlled substances: E:\FR\FM\31MR1.SGM 31MR1

Agencies

[Federal Register Volume 76, Number 62 (Thursday, March 31, 2011)]
[Notices]
[Page 17967]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-7537]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated October 8, 2010, and published in the Federal 
Register on October 20, 2010 75 FR 64744, Hospira Inc., 1776 North 
Centennial Drive, McPherson, Kansas 67460-1247, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as an importer of Remifentanil (9739), a basic class of controlled 
substance listed in schedule II.
    The company plans to import Remifentanil for use in dosage form 
manufacturing.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a), and determined that the 
registration of Hospira Inc. to import the basic class of controlled 
substance is consistent with the public interest, and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971, at this time. DEA has investigated 
Hospira Inc. to ensure that the company's registration is consistent 
with the public interest. The investigation has included inspection and 
testing of the company's physical security systems, verification of the 
company's compliance with state and local laws, and a review of the 
company's background and history. Therefore, pursuant to 21 U.S.C. 
952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above 
named company is granted registration as an importer of the basic class 
of controlled substance listed.

    Dated: March 21, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2011-7537 Filed 3-30-11; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.